Delivery Order SPE2DB24D2010-SPE2DB25FZWW8

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,774.62, is for the delivery of lisdexamfetamine 10 mg capsules in 100-count packages. The contract has an ultimate completion date of February 11, 2025 and is a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567342796 lisdexamfetamine 30 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,177.65, is for the delivery of 4,567,909,263 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.73, is a delivery order for the supply of lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price contract. No set-aside designation is mentioned. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,070.16, is for the delivery of lisdexamfetamine 40 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,862.41, is for the delivery of lisdexamfetamine 20 mg capsules in 100-count bottles. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation. The contract is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.25 delivery order contract is for the supply of Lisdexamfetamine 20 mg capsules, a medication used to treat certain medical conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,629.34 and is for the delivery of lisdexamfetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.80 fixed-price delivery order is for the supply of 4,568,225,703 units of the prescription medication lisdexamfetamine 10 mg capsules. The contract has a performance period through May 12, 2025 and is not set aside for any small business designation. AmerisourceBergen holds a substantial $999,999,999.00...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZWW8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,690.65, is for the delivery of lisdexamfetamine 40 mg capsules in quantities of 100 to support federal healthcare programs. The contract has an ultimate completion date of March 28, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/26/25, 9:52 AM